Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the flow cytometry in oncology and immunology market right now?
In recent times, the market size for flow cytometry in oncology and immunology has experienced swift growth. It is projected to expand from $2.11 billion in 2024 to approximately $2.33 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. This substantial growth during the historic period is attributed to progress in cancer studies, expansion of immunology research, diagnostic uses, increase in autoimmune diseases, and advancements in drug development and clinical trials.
How fast Is the flow cytometry in oncology and immunology market expected to grow, and what’s its future value?
In the following years, the market of flow cytometry in oncology and immunology is predicted to experience a swift expansion. The market is forecasted to reach $3.46 billion in 2029 with a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this growth in the projected period include its amalgamation with genomics and proteomics, increasing use of single-cell analysis, wider applications in treating infectious diseases, a surge in cancer cases, and the emergence of point-of-care flow cytometry. Key trends in this period foresee the use of immunophenotyping in immunotherapy, the downsizing of flow cytometry systems, multiparametric analysis, a shift towards spectral flow cytometry, and cooperation in research activities.
Get your flow cytometry in oncology and immunology market report here!
What are the leading drivers of growth in the flow cytometry in oncology and immunology market?
The rise in cancer cases is anticipated to fuel the expansion of flow cytometry in the oncology and immunology sectors. Cancer refers to a collection of disorders characterized by the unregulated proliferation and distribution of abnormal cells in the body. Flow cytometry is a frequently employed method in oncology and immunology to examine cancer and immune cells. For example, in October 2022, Macmillan Cancer Support, a healthcare charity organization based in the UK, reported that there were 3 million cancer patients in 2020. This number is predicted to grow to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising incidence of cancer is stimulating the growth of flow cytometry in the oncology and immunology markets.
What are the key segments defining the flow cytometry in oncology and immunology market?
The flow cytometry in oncology and immunology market covered in this report is segmented –
1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp
Who are the key players steering the development of the flow cytometry in oncology and immunology market?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason
What emerging trends are influencing the growth of the flow cytometry in oncology and immunology market?
The adoption of cutting-edge technology is an emerging trend in the oncology and immunology flow cytometry market. Major firms involved in this sector are utilizing fresh technological approaches to retain their market standing. For instance, in September 2022, Becton Dickinson and Company, a medical tech provider based in the United States, introduced the BD Research Cloud for oncology and immunology flow cytometry. The BD Research Cloud is a cloud-based software solution that streamlines the flow cytometry process for researchers across a range of disciplines, including immunology, virology, infectious disease, and cancer monitoring, thus enabling the acceleration of higher-quality studies, and more rapid insights. Becton Dickinson is utilizing groundbreaking technologies such as BD Horizon RealYellow and RealBlue Reagents, in addition to the recently launched BD FACSDiscover S8 Cell Sorter with BD CellView Image Technology, to improve flow cytometry capabilities, thus empowering researchers to enhance and advance their innovative studies. BD Research Cloud, which is based on a industry-standard cloud structure, is particularly tailored for BD equipment and reagents.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469
Which regions are most influential in expanding the flow cytometry in oncology and immunology market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Immuno-Oncology Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024
Immunosuppressants Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: